Melflufen and dexamethasone versus pomalidomide and dexamethasone in relapsed refractory multiple myeloma

Cancer care in Needle Hospital, Hargeisa, Somaliland

Multiple myeloma (A cancer arising from plasma cells)

Interpreting the results of a clinical trial

Cost-benefit analysis of new cancer medicines: The difficult choices of governments

Geriatric oncology in resource-limited settings

Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer

Cancer pain management

Spindle cell lesions of the breast

The 2022 OncoAlert Colloquium Day 6: EONS Sessions

The 2022 OncoAlert Colloquium Day 5: GI Oncology

The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology